Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany

被引:81
作者
Bierbaum, G [1 ]
Fuchs, K [1 ]
Lenz, W [1 ]
Szekat, C [1 ]
Sahl, HG [1 ]
机构
[1] Univ Bonn, Inst Med Mikrobiol & Immunol, Natl Referenzzentrum Staphylokokken, D-53125 Bonn, Germany
关键词
D O I
10.1007/s100960050380
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A total of 457 Staphylococcus aureus strains from the culture collection of the National Reference Center for Staphylococci in Bonn, Germany, were screened for susceptibility to vancomycin because some Staphylococcus aureus strains are able to form subpopulations that show intermediate resistance to vancomycin. Two methicillin-resistant Staphylococcus aureus strains (isolated in 1993) exhibited intermediate resistance. One of these, Staphylococcus aureus 137-93, which displayed the genomic DNA fragment pattern of the northern German epidemic strain, appeared homogeneously resistant. Neither of these strains had been identified by routine susceptibility testing. The resistance of the German isolates was lower than that of the Japanese isolate Mu50. To determine whether a similar mechanism confers vancomycin resistance in Staphylococcus aureus Mu50 and 137-93, the intracellular cell wall precursor concentration was measured and was not found to be comparably increased in Staphylococcus aureus 137-93. In conclusion, strains showing intermediate resistance have been present in Germany for some time (at least since 1993), but the subpopulations with decreased sensitivity were overlooked during antibiotic susceptibility testing.
引用
收藏
页码:691 / 696
页数:6
相关论文
共 21 条
[1]   Glycopeptide resistance in enterococci [J].
Arthur, M ;
Reynolds, P ;
Courvalin, P .
TRENDS IN MICROBIOLOGY, 1996, 4 (10) :401-407
[2]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P813
[3]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR MORB MORTAL WKL, V46, P765
[4]   CHARACTERIZATION OF STAPHYLOCOCCUS-AUREUS ISOLATES WITH DECREASED SUSCEPTIBILITY TO VANCOMYCIN AND TEICOPLANIN - ISOLATION AND PURIFICATION OF A CONSTITUTIVELY PRODUCED PROTEIN ASSOCIATED WITH DECREASED SUSCEPTIBILITY [J].
DAUM, RS ;
GUPTA, S ;
SABBAGH, R ;
MILEWSKI, WM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05) :1066-1072
[5]   RAPID FIELD INVERSION GEL-ELECTROPHORESIS IN COMBINATION WITH AN RIBOSOMAL-RNA GENE PROBE IN THE EPIDEMIOLOGIC EVALUATION OF STAPHYLOCOCCI [J].
GOERING, RV ;
DUENSING, TD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :426-429
[6]   Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50 [J].
Hanaki, H ;
Labischinski, H ;
Inaba, Y ;
Kondo, N ;
Murakami, H ;
Hiramatsu, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (03) :315-320
[7]   Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [J].
Hanaki, H ;
Kuwahara-Arai, K ;
Boyle-Vavra, S ;
Daum, RS ;
Labischinski, H ;
Hiramatsu, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :199-209
[8]   Vancomycin resistance in Staphylococci [J].
Hiramatsu, K .
DRUG RESISTANCE UPDATES, 1998, 1 (02) :135-150
[9]   Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].
Hiramatsu, K ;
Aritaka, N ;
Hanaki, H ;
Kawasaki, S ;
Hosoda, Y ;
Hori, S ;
Fukuchi, Y ;
Kobayashi, I .
LANCET, 1997, 350 (9092) :1670-1673
[10]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136